# Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines

> **NCT02643433** · PHASE4 · COMPLETED · sponsor: **Centers for Disease Control and Prevention, China** · enrollment: 1043 (actual)

## Conditions studied

- Measles
- Rubella
- Japanese Encephalitis

## Interventions

- **BIOLOGICAL:** Measles-Rubella combined vaccine(MR)
- **BIOLOGICAL:** Japanese Encephalitis alive vaccine(JE)

## Key facts

- **NCT ID:** NCT02643433
- **Lead sponsor:** Centers for Disease Control and Prevention, China
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 1043 (ACTUAL)
- **Last updated:** 2016-08-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02643433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02643433, "Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02643433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*